Wang Ronghua 4
4 · Biostar Pharmaceuticals, Inc. · Filed Jun 17, 2011
Insider Transaction Report
Form 4
Wang Ronghua
DirectorChairman, CEO10% Owner
Transactions
- Purchase
Common Stock
2011-06-15$1.19/sh+14,350$17,077→ 9,153,173 total - Purchase
Common Stock
2011-06-14$1.23/sh+35,100$43,173→ 9,138,823 total - Purchase
Common Stock
2011-06-16$1.10/sh+13,800$15,180→ 9,166,973 total
Footnotes (1)
- [F1]Purchase made pursuant to the stock repurchase plan of the Reporting Person as previously approved by the Board of Directors.